Dr. Praveen Adusumilli is a highly experienced Medical Oncologist with over 12 years of expertise in diagnosing and treating a wide range of cancers. He specializes in molecular oncology, targeted therapy, immunotherapy, stem cell transplantation, and advanced cellular therapies, providing comprehensive, evidence based cancer care tailored to every patient’s unique medical needs.
Committed to delivering compassionate, patient centered care, Dr. Praveen Adusumilli creates personalized treatment plans focused on achieving the best possible outcomes. He actively contributes to clinical trials and advancements in oncology, while emphasizing preventive oncology, early detection, and innovative treatment approaches to improve both survival and quality of life.
Dr. Praveen Adusumilli has contributed to oncology research and medical literature, with published work exploring cancer treatment outcomes, survival, long term effects, and palliative care. His research reflects an ongoing commitment to advancing evidence based cancer care and improving treatment outcomes for patients.
Published in the Indian Journal of Medical and Paediatric Oncology, this research examines treatment challenges and survival outcomes among patients with HER2 positive breast cancer.
This study explores long term survival and late treatment related effects among paediatric Hodgkin lymphoma patients treated at a tertiary care centre in Southern India.
Published in the South Asian Journal of Cancer, this research presents the experience of a tertiary care institute in South India, focusing on palliative care and end of life outcomes.
Published in Clinical Lymphoma, Myeloma and Leukemia, this research examines survival outcomes associated with generic imatinib treatment in patients with chronic myeloid leukemia.
